Abstract: Antigenic peptides that bind to MHC Class II molecules with the shared epitope referred to as HLA-DR molecules are disclosed. More specifically, are citrullinated antigenic peptides having an increased affinity for HLA-DR molecules and associated with Rheumatoid arthritis. These novel peptides provide the basis for new methods of diagnosis and treatment of Rheumatoid arthritis.

Abstract: There is provided a stabilising composition for hot melt adhesives, the composition comprising: a first stabilising component comprising at least one phenolic antioxidant; a second stabilising component comprising at least one phosphite antioxidant; and a third stabilising component comprising at least one antioxidant containing a sulphur group having the formula —CH2-(S)x-CH2-, wherein x=1 or 2, and wherein neither of the —CH2- groups is directly bonded to an aromatic group.

Abstract: A load bearing flexible conduit system (10) for use in a body of water and adapted for deployment from a reel (100) located on a water going vessel into the body of water is disclosed. The system comprises a number of lengths (12) of load bearing flexible conduit, each length of load bearing flexible conduit provided with an inner layer (44) having a throughbore and a load bearing outer layer (50). A joint (30) for connecting the lengths together has a body having a longitudinal axis and a throughbore and at least one flexible coupling to permit at least one of the said one ends of the respective first and second lengths of load bearing flexible conduit to move relative to the longitudinal axis of the joint. The lengths of load bearing flexible conduit are sufficiently flexible such that they are capable of being stored, prior to use, on a reel (100) and are further capable of being at least partially payed out from the reel into the body of water during use.

Abstract: A composition comprising a mixture of at least two different alkylaryl phosphites, wherein some alkyl groups have a different number of carbon atoms than other alkyl groups and wherein the mixture is a liquid at ambient conditions.

Abstract: Antigenic peptides that bind to MHC Class II molecules with the shared epitope referred to as HLA-DR molecules are disclosed. More specifically, are citrullinated antigenic peptides having an increased affinity for HLA-DR molecules and associated with rheumatoid arthritis. These novel peptides provide the basis for new methods of diagnosis and treatment of rheumatoid arthritis.

Abstract: Antigenic peptides that bind to MHC Class II molecules with the shared epitope referred to as HLA-DR molecules are disclosed. More specifically, are citrullinated antigenic peptides having an increased affinity for HLA-DR molecules and associated with Rheumatoid Arthritis. These novel peptides provide the basis for new methods of diagnosis and treatment of Rheumatoid Arthritis.

Abstract: A composition at least two different phosphites, one of which is derived from an alkylated cresol, wherein the composition is a liquid at ambient conditions. The other phosphites may be derived from alkylated cresol, alkylated phenol or other alkylated hydroxyaryl compounds. The cresol may be mono-alkylated or di-alkylated with a C1-C18 alkyl group.

Abstract: A composition comprising at least two different alkylaryl phosphites, wherein some alkyl groups have a different number of carbon atoms than other alkyl groups and wherein the composition is a liquid at ambient conditions.

Abstract: Alkylate compositions comprising a monoamylphenol in an amount ranging from 25 weight percent to 99 weight percent and a diamylphenol in an amount ranging from 1 weight percent to 60 weight percent, the weight percentages being based on the total weight of all components in the alkylate composition. The invention is also to processes for making such alkylate compositions and to processes for forming stable liquid amylaryl phosphite compositions from such alkylate compositions.

Abstract: Hydrolytically stable phosphites as secondary antioxidants for polymer resins comprising a phosphite and an amine compound. The phosphite may be a liquid phosphite composition. The amine compound may have the structure of formula I: wherein x is 1, 2 or 3; R1 is selected from the group consisting of hydrogen, and straight or branched C1-C6 alkyl, and R2 is selected from the group consisting of straight or branched C1-C30 alkyl.

Abstract: Alkylate compositions comprising a monobutylphenol in an amount ranging from 50 weight percent to 99 weight percent and a dibutylphenol in an amount ranging from 1 weight percent to 50 weight percent, the weight percentages being based on the total weight of all components in the alkylate composition. The invention is also to processes for making such alkylate compositions and to processes for forming stable liquid butylaryl phosphite compositions from such alkylate compositions.

Abstract: A composition at least two different phosphites, one of which is derived from an alkylated cresol, wherein the composition is a liquid at ambient conditions. The other phosphites may be derived from alkylated cresol, alkylated phenol or other alkylated hydroxyaryl compounds. The cresol may be mono-alkylated or di-alkylated with a C1-C18 alkyl group.

Abstract: Alkylate compositions comprising a monoamylphenol in an amount ranging from 25 weight percent to 99 weight percent and a diamylphenol in an amount ranging from 1 weight percent to 60 weight percent, the weight percentages being based on the total weight of all components in the alkylate composition. The invention is also to processes for making such alkylate compositions and to processes for forming stable liquid amylaryl phosphite compositions from such alkylate compositions.

Abstract: A composition comprising at least two different alkylaryl phosphites, wherein some alkyl groups have a different number of carbon atoms than other alkyl groups and wherein the composition is a liquid at ambient conditions.

Abstract: Antigenic peptides that bind to MHC Class II molecules with the shared epitope referred to as HLA-DR molecules are disclosed. More specifically, are citrullinated antigenic peptides having an increased affinity for HLA-DR molecules and associated with Rheumatoid Arthritis. These novel peptides provide the basis for new methods of diagnosis and treatment of Rheumatoid Arthritis.

Abstract: Antigenic peptides that bind to MHC Class II molecules with the shared epitope referred to as HLA-DR molecules are disclosed. More specifically, are citrullinated antigenic peptides having an increased affinity for HLA-DR molecules and associated with Rheumatoid arthritis. These novel peptides provide the basis for new methods of diagnosis and treatment of Rheumatoid arthritis.